New strategy for rational use of antihypertensive drugs in clinical practice in high-altitude hypoxic environments

References

• Abdullahi W, Davis TP, Ronaldson PT. 2017. Functional expression of P-glycoprotein and organic anion transporting polypeptides at the blood-brain barrier: understanding transport mechanisms for improved CNS drug delivery? Aaps J. 19(4):931–939. doi: 10.1208/s12248-017-0081-9.
   PubMed Web of Science ®Google Scholar
• Ames MK, Atkins CE, Pitt B. 2019. The renin-angiotensin-aldosterone system and its suppression. J Vet Intern Med. 33(2):363–382. doi: 10.1111/jvim.15454.
   PubMed Web of Science ®Google Scholar
• Antezana AM, Richalet JP, Antezana G, Spielvogel H, Kacimi R. 1992. Adrenergic system in high altitude residents. Int J Sports Med. 13 Suppl 1(S 1):S96–S100. doi: 10.1055/s-2007-1024608.
   PubMedGoogle Scholar
• Arancibia A, Nella Gai M, Paulos C, Chávez J, Pinilla E, Angel N, Ritschel WA. 2004. Effects of high altitude exposure on the pharmacokinetics of furosemide in healthy volunteers. Int J Clin Pharmacol Ther. 42(6):314–320. doi: 10.5414/cpp42314.
   PubMed Web of Science ®Google Scholar
• Bai X, Yang J, Liu G, Zhu J, Wang Q, Gu W, La L, Li X. 2022. Regulation of CYP450 and drug transporter mediated by gut microbiota under high-altitude hypoxia. Front Pharmacol. 13:977370. doi: 10.3389/fphar.2022.977370.
   PubMed Web of Science ®Google Scholar
• Barakat M, Du Souich P. 1996. Effect of nifedipine on the elimination of theophylline in the rabbit subjected to hypoxia or to an inflammatory reaction. J Pharm Pharmacol. 48(9):906–910. doi: 10.1111/j.2042-7158.1996.tb05999.x.
   PubMed Web of Science ®Google Scholar
• Bärtsch P, Maggiorini M, Ritter M, Noti C, Vock P, Oelz O. 1991. Prevention of high-altitude pulmonary edema by nifedipine. N Engl J Med. 325(18):1284–1289. doi: 10.1056/NEJM199110313251805.
   PubMed Web of Science ®Google Scholar
• Bilo G, Caldara G, Styczkiewicz K, Revera M, Lombardi C, Giglio A, Zambon A, Corrao G, Faini A, Valentini M, et al. 2011. Effects of selective and nonselective beta-blockade on 24-h ambulatory blood pressure under hypobaric hypoxia at altitude. J Hypertens. 29(2):380–387. doi: 10.1097/HJH.0b013e3283409014.
   PubMed Web of Science ®Google Scholar
• Bilo G, Caravita S, Torlasco C, Parati G. 2019. Blood pressure at high altitude: physiology and clinical implications. Kardiol Pol. 77(6):596–603. doi: 10.33963/KP.14832.
   PubMed Web of Science ®Google Scholar
• Bilo G, Villafuerte FC, Faini A, Anza-Ramírez C, Revera M, Giuliano A, Caravita S, Gregorini F, Lombardi C, Salvioni E, et al. 2015. Ambulatory blood pressure in untreated and treated hypertensive patients at high altitude: the high altitude cardiovascular research-Andes study. Hypertension. 65(6):1266–1272. doi: 10.1161/HYPERTENSIONAHA.114.05003.
   PubMed Web of Science ®Google Scholar
• Botero R, Matiz H, María E, Orejarena H, Blanco M, Velez JR, Del Portillo H. 2000. Efficacy and safety of valsartan compared with enalapril at different altitudes. Int J Cardiol. 72(3):247–254. doi: 10.1016/s0167-5273(99)00194-1.
   PubMed Web of Science ®Google Scholar
• Brito J, Siqués P, León-Velarde F, De La Cruz JJ, López V, Herruzo R. 2007. Chronic intermittent hypoxia at high altitude exposure for over 12 years: assessment of hematological, cardiovascular, and renal effects. High Alt Med Biol. 8(3):236–244. doi: 10.1089/ham.2007.8310.
   PubMed Web of Science ®Google Scholar
• Calbet JA. 2003. Chronic hypoxia increases blood pressure and noradrenaline spillover in healthy humans. J Physiol. 551(Pt 1):379–386. doi: 10.1113/jphysiol.2003.045112.
   PubMed Web of Science ®Google Scholar
• Calbet JA, Boushel R, Robach P, Hellsten Y, Saltin B, Lundby C. 2014. Chronic hypoxia increases arterial blood pressure and reduces adenosine and ATP induced vasodilatation in skeletal muscle in healthy humans. Acta Physiol (Oxf). 211(4):574–584. doi: 10.1111/apha.12325.
   PubMed Web of Science ®Google Scholar
• Caravita S, Faini A, Baratto C, Bilo G, Macarlupu JL, Lang M, Revera M, Lombardi C, Villafuerte FC, Agostoni P, et al. 2018. Upward shift and steepening of the blood pressure response to exercise in hypertensive subjects at high altitude. J Am Heart Assoc. 7(12): e008506. doi: 10.1161/JAHA.117.008506.
   PubMed Web of Science ®Google Scholar
• Caravita S, Faini A, Bilo G, Lang M, Parati G,2016. Role of acetazolamide and telmisartan/nifedipine-GITS combination in antagonizing the blood pressure rise induced by high altitude exposure. Int J Cardiol. 225:324–326. doi: 10.1016/j.ijcard.2016.09.094.
   PubMed Web of Science ®Google Scholar
• Dallas S, Miller DS, Bendayan R. 2006. Multidrug resistance-associated proteins: expression and function in the central nervous system. Pharmacol Rev. 58(2):140–161. doi: 10.1124/pr.58.2.3.
   PubMed Web of Science ®Google Scholar
• Dorababu M, Nishimura A, Prabha T, Naruhashi K, Sugioka N, Takada K, Shibata N. 2009. Effect of cyclosporine on drug transport and pharmacokinetics of nifedipine. Biomed Pharmacother. 63(9):697–702. doi: 10.1016/j.biopha.2009.04.031.
   PubMed Web of Science ®Google Scholar
• Du Souich P, Hartemann D, Saunier C. 1993. Effect of acute and chronic moderate hypoxia on diltiazem kinetics and metabolism in the dog. Pharmacology. 47(6):378–385. doi: 10.1159/000139121.
   PubMed Web of Science ®Google Scholar
• Duan Y, Bai X, Yang J, Zhou Y, Gu W, Liu G, Wang Q, Zhu J, La L, Li X. 2022. Exposure to high-altitude environment is associated with drug transporters change: microRNA-873-5p-Mediated alteration of function and expression levels of drug transporters under hypoxia. Drug Metab Dispos. 50(2):174–186. doi: 10.1124/dmd.121.000681.
   PubMed Web of Science ®Google Scholar
• Duan YB, Zhu JB, Yang JX, Liu GQ, Bai X, Qu N, Wang XJ, Li XY. 2020. Regulation of high-altitude hypoxia on the transcription of CYP450 and UGT1A1 mediated by PXR and CAR. Front Pharmacol. 11:574176. doi: 10.3389/fphar.2020.574176.
   PubMed Web of Science ®Google Scholar
• Faulhaber M, Flatz M, Burtscher M. 2003. Beta-blockers may provoke oxygen desaturation during submaximal exercise at moderate altitudes in elderly persons. High Alt Med Biol. 4(4):475–478. doi: 10.1089/152702903322616227.
   PubMed Web of Science ®Google Scholar
• Fradette C, Batonga J, Teng S, Piquette-Miller M, Du Souich P. 2007. Animal models of acute moderate hypoxia are associated with a down-regulation of CYP1A1, 1A2, 2B4, 2C5, and 2C16 and up-regulation of CYP3A6 and P-glycoprotein in liver. Drug Metab Dispos. 35(5):765–771. doi: 10.1124/dmd.106.013508.
   PubMed Web of Science ®Google Scholar
• Fradette C, Bleau AM, Pichette V, Chauret N, Du Souich P. 2002. Hypoxia-induced down-regulation of CYP1A1/1A2 and up-regulation of CYP3A6 involves serum mediators. Br J Pharmacol. 137(6):881–891. doi: 10.1038/sj.bjp.0704933.
   PubMed Web of Science ®Google Scholar
• Freudenthaler SM, Schreeb K, Körner T, Gleiter CH. 1999. Angiotensin II increases erythropoietin production in healthy human volunteers. Eur J Clin Invest. 29(10):816–823. doi: 10.1046/j.1365-2362.1999.00530.x.
   PubMed Web of Science ®Google Scholar
• Gamboa A, Gamboa JL, Holmes C, Sharabi Y, Leon-Velarde F, Fischman GJ, Appenzeller O, Goldstein DS. 2006. Plasma catecholamines and blood volume in native Andeans during hypoxia and normoxia. Clin Auton Res. 16(1):40–45. doi: 10.1007/s10286-006-0305-z.
   PubMed Web of Science ®Google Scholar
• Hainsworth R, Drinkhill MJ, Rivera-Chira M. 2007. The autonomic nervous system at high altitude. Clin Auton Res. 17(1):13–19. doi: 10.1007/s10286-006-0395-7.
   PubMed Web of Science ®Google Scholar
• Hamelin BA, Bouayad A, Méthot J, Jobin J, Desgagnés P, Poirier P, Allaire J, Dumesnil J, Turgeon J. 2000. Significant interaction between the nonprescription antihistamine diphenhydramine and the CYP2D6 substrate metoprolol in healthy men with high or low CYP2D6 activity. Clin Pharmacol Ther. 67(5):466–477. doi: 10.1067/mcp.2000.106464.
   PubMed Web of Science ®Google Scholar
• Hernández-Hernández R, Silva H, Velasco M, Pellegrini F, Macchia A, Escobedo J, Vinueza R, Schargrodsky H, Champagne B, Pramparo P, et al. 2010. Hypertension in seven Latin American cities: the cardiovascular risk factor multiple evaluation in Latin America (CARMELA) study. J Hypertens. 28(1):24–34. doi: 10.1097/HJH.0b013e328332c353.
   PubMed Web of Science ®Google Scholar
• Jin T, Luo B, Zhang X, Li W, Zhang J, Zhang M, Wang Ch Zhao A, Wang R. 2017. Difference of effect of hypoxia on gene expression of six drug transporters in rats. Pharm J Chin. 33:297–301.
   Google Scholar
• Johnson NJ, Luks AM. 2016. High-altitude medicine. Med Clin North Am. 100(2):357–369. doi: 10.1016/j.mcna.2015.09.002.
   PubMed Web of Science ®Google Scholar
• Jones DP. 1981. Hypoxia and drug metabolism. Biochem Pharmacol. 30(10):1019–1023. doi: 10.1016/0006-2952(81)90436-6.
   PubMed Web of Science ®Google Scholar
• Jürgens G, Christensen HR, Brøsen K, Sonne J, Loft S, Olsen NV. 2002. Acute hypoxia and cytochrome P450-mediated hepatic drug metabolism in humans. Clin Pharmacol Ther. 71(4):214–220. doi: 10.1067/mcp.2002.121789.
   PubMed Web of Science ®Google Scholar
• Keynes RJ, Smith GW, Slater JD, Brown MM, Brown SE, Payne NN, Jowett TP, Monge CC. 1982. Renin and aldosterone at high altitude in Man. J Endocrinol. 92(1):131–140. doi: 10.1677/joe.0.0920131.
   PubMed Web of Science ®Google Scholar
• Koepsell H. 2020. Organic cation transporters in health and disease. Pharmacol Rev. 72(1):253–319. doi: 10.1124/pr.118.015578.
   PubMed Web of Science ®Google Scholar
• Kumar R, Qadar Pasha MA, Khan AP, Gupta V, Grover SK, Norboo T, Srivastava KK, Selvamurthy W, Brahamchari SK. 2003. Association of high-altitude systemic hypertension with the deletion allele-of the angiotensin-converting enzyme (ACE) gene. Int J Biometeorol. 48(1):10–14. doi: 10.1007/s00484-003-0172-4.
   PubMed Web of Science ®Google Scholar
• Kurdi J, Maurice H, El-Kadi AO, Ong H, Dalkara S, Bélanger PM, Souich P. 1999. Effect of hypoxia alone or combined with inflammation and 3-methylcholanthrene on hepatic cytochrome P450 in conscious rabbits. Br J Pharmacol. 128(2):365–373. doi: 10.1038/sj.bjp.0702795.
   PubMed Web of Science ®Google Scholar
• Lang M, Faini A, Caravita S, Bilo G, Anza-Ramìrez C, Villafuerte FC, Macarlupu JL, Salvioni E, Agostoni P, Parati G. 2016. Blood pressure response to six-minute walk test in hypertensive subjects exposed to high altitude: effects of antihypertensive combination treatment. Int J Cardiol. 219:27–32. doi: 10.1016/j.ijcard.2016.04.169.
   PubMed Web of Science ®Google Scholar
• Li WB, Wang R, Xie H, Zhang JH, Xie XH, Wu XY, Jia ZP. 2012. [Effects on the pharmacokinetics of furosemide after acute exposure to high altitude at 4010 meters in rats]. Yao Xue Xue Bao. 47(12):1718–1721.
   PubMedGoogle Scholar
• Li X, Wang X, Li Y, Yuan M, Zhu J, Su X, Yao X, Fan X, Duan Y. 2014a. Effect of exposure to acute and chronic high-altitude hypoxia on the activity and expression of CYP1A2, CYP2D6, CYP2C9, CYP2C19 and NAT2 in rats. Pharmacology. 93(1-2):76–83. doi: 10.1159/000358128.
   PubMed Web of Science ®Google Scholar
• Li X, Wang X, Li Y, Zhu J, Su X, Yao X, Fan X, Duan Y. 2014b. The activity, protein, and mRNA expression of CYP2E1 and CYP3A1 in rats after exposure to acute and chronic high altitude hypoxia. High Alt Med Biol. 15(4):491–496. doi: 10.1089/ham.2014.1026.
   PubMedGoogle Scholar
• Liu LS, Wu ZS, Wang JG, Wang W, Bao YJ, Cai J, Chen LY, Chen WW, Chu SL, Feng YQ, et al. 2019. 2018 Chinese guidelines for prevention and treatment of hypertension-A report of the revision committee of Chinese guidelines for prevention and treatment of hypertension. J Geriatr Cardiol. 16:182–245.
   PubMedGoogle Scholar
• Liu Y, Zhang JH, Gao XB, Wu XJ, Yu J, Chen JF, Bian SZ, Ding XH, Huang L. 2014. Correlation between blood pressure changes and AMS, sleeping quality and exercise upon high-altitude exposure in young Chinese men. Mil Med Res. 1:19. doi: 10.1186/2054-9369-1-19.
   PubMedGoogle Scholar
• Luks AM. 2009. Should travelers with hypertension adjust their medications when traveling to high altitude? High Alt Med Biol. 10(1):11–15. doi: 10.1089/ham.2008.1076.
   PubMed Web of Science ®Google Scholar
• Luks AM, Hackett PH. 2022. Medical conditions and high-altitude travel. N Engl J Med. 386(4):364–373. doi: 10.1056/NEJMra2104829.
   PubMed Web of Science ®Google Scholar
• Luo B, Li J, Yang T, Li W, Zhang J, Wang C, Zhao A, Wang R. 2018. Evaluation of renal excretion and pharmacokinetics of furosemide in rats after acute exposure to high altitude at 4300 m. Biopharm Drug Dispos. 39(8):378–387. doi: 10.1002/bdd.2154.
   PubMed Web of Science ®Google Scholar
• Mahajan S, Gu J, Caraballo C, Lu Y, Spatz ES, Zhao H, Zhang M, Sun N, Zheng X, Lu H, et al. 2020. Relationship of age with the hemodynamic parameters in individuals with elevated blood pressure. J Am Geriatr Soc. 68(7):1520–1528. doi: 10.1111/jgs.16411.
   PubMed Web of Science ®Google Scholar
• Matthaei J, Brockmöller J, Tzvetkov MV, Sehrt D, Sachse-Seeboth C, Hjelmborg JB, Möller S, Halekoh U, Hofmann U, Schwab M, et al. 2015. Heritability of metoprolol and torsemide pharmacokinetics. Clin Pharmacol Ther. 98(6):611–621. doi: 10.1002/cpt.258.
   PubMed Web of Science ®Google Scholar
• Mazzeo RS, Bender PR, Brooks GA, Butterfield GE, Groves BM, Sutton JR, Wolfel EE, Reeves JT. 1991. Arterial catecholamine responses during exercise with acute and chronic high-altitude exposure. Am J Physiol. 261(4 Pt 1):E419–E424. doi: 10.1152/ajpendo.1991.261.4.E419.
   PubMedGoogle Scholar
• Mazzeo RS, Carroll JD, Butterfield GE, Braun B, Rock PB, Wolfel EE, Zamudio S, Moore LG. 2001. Catecholamine responses to alpha-adrenergic blockade during exercise in women acutely exposed to altitude. J Appl Physiol (1985). 90(1):121–126. doi: 10.1152/jappl.2001.90.1.121.
   PubMed Web of Science ®Google Scholar
• Mazzeo RS, Child A, Butterfield GE, Mawson JT, Zamudio S, Moore LG. 1998. Catecholamine response during 12 days of high-altitude exposure (4300 m) in Women. J Appl Physiol (1985). 84(4):1151–1157. doi: 10.1152/jappl.1998.84.4.1151.
   PubMed Web of Science ®Google Scholar
• Messerli FH, Bavishi C, Bangalore S. 2022. Why are we still prescribing angiotensin-converting enzyme inhibitors? Circulation. 145(6):413–415. doi: 10.1161/CIRCULATIONAHA.121.057835.
   PubMed Web of Science ®Google Scholar
• Milledge JS, Catley DM, Blume FD, West JB. 1983. Renin, angiotensin-converting enzyme, and aldosterone in humans on Mount Everest. J Appl Physiol Respir Environ Exerc Physiol. 55(4):1109–1112. doi: 10.1152/jappl.1983.55.4.1109.
   PubMed Web of Science ®Google Scholar
• Mingji C, Onakpoya IJ, Perera R, Ward AM, Heneghan CJ. 2015. Relationship between altitude and the prevalence of hypertension in Tibet: a systematic review. Heart. 101(13):1054–1060. doi: 10.1136/heartjnl-2014-307158.
   PubMed Web of Science ®Google Scholar
• Molden E, Asberg A, Christensen H. 2000. CYP2D6 is involved in O-demethylation of diltiazem. An in vitro study with transfected human liver cells. Eur J Clin Pharmacol. 56(8):575–579. doi: 10.1007/s002280000182.
   PubMed Web of Science ®Google Scholar
• Moore LG. 2001. Human genetic adaptation to high altitude. High Alt Med Biol. 2(2):257–279. doi: 10.1089/152702901750265341.
   PubMed Web of Science ®Google Scholar
• Moraga FA, López I, Morales A, Soza D, Noack J. 2018. The Effect of oxygen enrichment on cardiorespiratory and neuropsychological responses in workers with chronic intermittent exposure to high altitude (ALMA, 5,050 m). Front Physiol. 9:187. doi: 10.3389/fphys.2018.00187.
   PubMed Web of Science ®Google Scholar
• Narvaez-Guerra O, Herrera-Enriquez K, Medina-Lezama J, Chirinos JA. 2018. Systemic hypertension at high altitude. Hypertension. 72(3):567–578. doi: 10.1161/HYPERTENSIONAHA.118.11140.
   PubMed Web of Science ®Google Scholar
• Negi PC, Bhardwaj R, Kandoria A, Asotra S, Ganju N, Marwaha R, Sharma R, Kanwar A. 2012. Epidemiological study of hypertension in natives of Spiti Valley in Himalayas and impact of hypobaric hypoxemia; a cross-sectional study. J Assoc Physicians India. 60:21–25.
   PubMedGoogle Scholar
• Nigam SK. 2015. What do drug transporters really do? Nat Rev Drug Discov. 14(1):29–44. doi: 10.1038/nrd4461.
   PubMed Web of Science ®Google Scholar
• Norboo T, Stobdan T, Tsering N, Angchuk N, Tsering P, Ahmed I, Chorol T, Kumar Sharma V, Reddy P, Singh SB, et al. 2015. Prevalence of hypertension at high altitude: cross-sectional survey in Ladakh, Northern India 2007–2011. BMJ Open. 5(4):e007026–e007026. doi: 10.1136/bmjopen-2014-007026.
   PubMed Web of Science ®Google Scholar
• Oparil S, Acelajado MC, Bakris GL, Berlowitz DR, Cífková R, Dominiczak AF, Grassi G, Jordan J, Poulter NR, Rodgers A, et al. 2018. Hypertension. Nat Rev Dis Primers. 4(1):18014. doi: 10.1038/nrdp.2018.14.
   PubMedGoogle Scholar
• Otsuka K, Norboo T, Otsuka Y, Higuchi H, Hayajiri M, Narushima C, Sato Y, Tsugoshi T, Murakami S, Wada T, et al. 2005. Effect of aging on blood pressure in Leh, Ladakh, a high-altitude (3524 m) community, by comparison with a Japanese Town. Biomed Pharmacother. 59 Suppl 1(Suppl 1):S54–S57. doi: 10.1016/s0753-3322(05)80011-3.
   PubMedGoogle Scholar
• Parati G, Agostoni P, Basnyat B, Bilo G, Brugger H, Coca A, Festi L, Giardini G, Lironcurti A, Luks AM, et al. 2018. Clinical recommendations for high altitude exposure of individuals with pre-existing cardiovascular conditions: a joint statement by the European Society of Cardiology, the council on hypertension of the European Society of Cardiology, the European Society of Hypertension, the International Society of mountain Medicine, the Italian society of hypertension and the Italian society of mountain Medicine. Eur Heart J. 39(17):1546–1554. doi: 10.1093/eurheartj/ehx720.
   PubMed Web of Science ®Google Scholar
• Parati G, Bilo G, Faini A, Bilo B, Revera M, Giuliano A, Lombardi C, Caldara G, Gregorini F, Styczkiewicz K, et al. 2014. Changes in 24 h ambulatory blood pressure and effects of angiotensin II receptor blockade during acute and prolonged high-altitude exposure: a randomized clinical trial. Eur Heart J. 35(44):3113–3122. doi: 10.1093/eurheartj/ehu275.
   PubMed Web of Science ®Google Scholar
• Parati G, Revera M, Giuliano A, Faini A, Bilo G, Gregorini F, Lisi E, Salerno S, Lombardi C, Ramos Becerra CG, et al. 2013. Effects of acetazolamide on central blood pressure, peripheral blood pressure, and arterial distensibility at acute high altitude exposure. Eur Heart J. 34(10):759–766. doi: 10.1093/eurheartj/ehs140.
   PubMed Web of Science ®Google Scholar
• Pauca AL, Wallenhaupt SL, Kon ND, Tucker WY. 1992. Does radial artery pressure accurately reflect aortic pressure? Chest. 102(4):1193–1198. doi: 10.1378/chest.102.4.1193.
   PubMed Web of Science ®Google Scholar
• Piperno A, Galimberti S, Mariani R, Pelucchi S, Ravasi G, Lombardi C, Bilo G, Revera M, Giuliano A, Faini A, et al. 2011. Modulation of hepcidin production during hypoxia-induced erythropoiesis in humans in vivo: data from the HIGHCARE project. Blood. 117(10):2953–2959. doi: 10.1182/blood-2010-08-299859.
   PubMed Web of Science ®Google Scholar
• Pontremoli R, Leoncini G, Parodi A. 2005. Use of nifedipine in the treatment of hypertension. Expert Rev Cardiovasc Ther. 3(1):43–50. doi: 10.1586/14779072.3.1.43.
   PubMedGoogle Scholar
• Pratt MC, Lewis-Barned NJ, Walker RJ, Bailey RR, Shand BI, Livesey J. 1992. Effect of angiotensin converting enzyme inhibitors on erythropoietin concentrations in healthy volunteers. Br J Clin Pharmacol. 34(4):363–365. doi: 10.1111/j.1365-2125.1992.tb05644.x.
   PubMed Web of Science ®Google Scholar
• Revera M, Salvi P, Faini A, Giuliano A, Gregorini F, Bilo G, Lombardi C, Mancia G, Agostoni P, Parati G, 2017. Renin-angiotensin-aldosterone system is not involved in the arterial stiffening induced by acute and prolonged exposure to high altitude. Hypertension. 70(1):75–84. doi: 10.1161/HYPERTENSIONAHA.117.09197.
   PubMed Web of Science ®Google Scholar
• Richalet JP, Donoso MV, Jiménez D, Antezana AM, Hudson C, Cortès G, Osorio J, Leòn A. 2002. Chilean miners commuting from sea level to 4500 m: a prospective study. High Alt Med Biol. 3(2):159–166. doi: 10.1089/15270290260131894.
   PubMed Web of Science ®Google Scholar
• Rimoldi SF, Sartori C, Seiler C, Delacrétaz E, Mattle HP, Scherrer U, Allemann Y. 2010. High-altitude exposure in patients with cardiovascular disease: risk assessment and practical recommendations. Prog Cardiovasc Dis. 52(6):512–524. doi: 10.1016/j.pcad.2010.03.005.
   PubMed Web of Science ®Google Scholar
• Ritschel WA, Paulos C, Arancibia A, Agrawal MA, Wetzelsberger KM, Lücker PW. 1998. Pharmacokinetics of acetazolamide in healthy volunteers after short- and long-term exposure to high altitude. J Clin Pharmacol. 38(6):533–539. doi: 10.1002/j.1552-4604.1998.tb05791.x.
   PubMed Web of Science ®Google Scholar
• Roth M, Obaidat A, Hagenbuch B. 2012. OATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamilies. Br J Pharmacol. 165(5):1260–1287. doi: 10.1111/j.1476-5381.2011.01724.x.
   PubMed Web of Science ®Google Scholar
• Scherrer U, Vollenweider L, Delabays A, Savcic M, Eichenberger U, Kleger GR, Fikrle A, Ballmer PE, Nicod P, Bärtsch P. 1996. Inhaled nitric oxide for high-altitude pulmonary edema. N Engl J Med. 334(10):624–629. doi: 10.1056/NEJM199603073341003.
   PubMed Web of Science ®Google Scholar
• Sevrioukova IF, Poulos TL. 2013. Understanding the mechanism of cytochrome P450 3A4: recent advances and remaining problems. Dalton Trans. 42(9):3116–3126. doi: 10.1039/c2dt31833d.
   PubMed Web of Science ®Google Scholar
• Siqués P, Brito J, Banegas JR, León-Velarde F, de la Cruz-Troca JJ, López V, Naveas N, Herruzo R. 2009. Blood pressure responses in young adults first exposed to high altitude for 12 months at 3550 m. High Alt Med Biol. 10(4):329–335. doi: 10.1089/ham.2008.1103.
   PubMed Web of Science ®Google Scholar
• Streit M, Göggelmann C, Dehnert C, Burhenne J, Riedel KD, Menold E, Mikus G, Bärtsch P, Haefeli WE. 2005. Cytochrome P450 enzyme-mediated drug metabolism at exposure to acute hypoxia (Corresponding to an altitude of 4500 m). Eur J Clin Pharmacol. 61(1):39–46. doi: 10.1007/s00228-004-0886-1.
   PubMed Web of Science ®Google Scholar
• Sutton D, Butler AM, Nadin L, Murray M. 1997. Role of CYP3A4 in human hepatic diltiazem N-demethylation: inhibition of CYP3A4 activity by oxidized diltiazem metabolites. J Pharmacol Exp Ther. 282(1):294–300.
   PubMed Web of Science ®Google Scholar
• Swenson ER. 2004. ACE inhibitors and high altitude. High Alt Med Biol. 5(1):92–94. doi: 10.1089/152702904322963762.
   PubMed Web of Science ®Google Scholar
• Swenson ER. 2014. New insights into carbonic anhydrase inhibition, vasodilation, and treatment of hypertensive-related diseases. Curr Hypertens Rep. 16(9):467. doi: 10.1007/s11906-014-0467-3.
   PubMed Web of Science ®Google Scholar
• Tan Z, Dong H, Yang L, Xiong H, Huang F, Pu C, Bai Z. 2018. [Prevalence and risk factors of hypertension among Tibetan community residents in Lhasa City]. MEDS Public Health and Preventive Medicine. 29(2): 130–133. Chinese.
   Google Scholar
• Tornio A, Backman JT. 2018. Cytochrome P450 in pharmacogenetics: an update. Adv Pharmacol. 83:3–32. doi: 10.1016/bs.apha.2018.04.007.
   PubMedGoogle Scholar
• Velasco A, Vongpatanasin W, Levine BD. 2014. Treating hypertension at high altitude: the quest for a magic bullet continues. Eur Heart J. 35(44):3083–3084. doi: 10.1093/eurheartj/ehu366.
   PubMed Web of Science ®Google Scholar
• Vij AG, Kishore K, Dey J. 2012. Effect of intermittent hypobaric hypoxia on efficacy & clearance of drugs. Indian J Med Res. 135:211–216.
   PubMed Web of Science ®Google Scholar
• Wenbin L, Rong W, Hua X, Juanhong Z, Xiaoyu W, Zhengping J. 2015. Effects on pharmacokinetics of propranolol and other factors in rats after acute exposure to high altitude at 4,010 m. Cell Biochem Biophys. 72(1):27–36. doi: 10.1007/s12013-014-0397-3.
   PubMed Web of Science ®Google Scholar
• Williams B, Lacourcière Y, Schumacher H, Gosse P, Neutel JM. 2009. Antihypertensive Efficacy of telmisartan vs ramipril over the 24-h dosing period, including the critical early morning hours: a pooled analysis of the PRISMA I and II randomized trials. J Hum Hypertens. 23(9):610–619. doi: 10.1038/jhh.2009.4.
   PubMed Web of Science ®Google Scholar
• Wolfel EE, Selland MA, Mazzeo RS, Reeves JT. 1994. Systemic hypertension at 4,300 m is related to sympathoadrenal activity. J Appl Physiol (1985). 76(4):1643–1650. doi: 10.1152/jappl.1994.76.4.1643.
   PubMed Web of Science ®Google Scholar
• Wu T-Y, Ding SQ, Liu JL, Yu MT, Jia JH, Chai ZC, Dai RC, Zhang SL, Li BY, Pan L, et al. 2007. Who should not go High: chronic disease and work at altitude during construction of the Qinghai-Tibet railroad. High Alt Med Biol. 8(2):88–107. doi: 10.1089/ham.2007.1015.
   PubMed Web of Science ®Google Scholar
• Yanamandra U, Singh SP, Yanamandra S, Mulajkar D, Grewal RS, Singh S, Ashraf MZ, Reddy P, Nair V. 2017. Endothelial markers in high altitude induced systemic hypertension (HASH) at moderate high altitude. Med J Armed Forces India. 73(4):363–369. doi: 10.1016/j.mjafi.2017.09.010.
   PubMedGoogle Scholar
• Zhang J, Wang H, Fan Y, Yu Z, You G. 2021. Regulation of organic anion transporters: role in physiology, pathophysiology, and drug elimination. Pharmacol Ther. 217:107647. doi: 10.1016/j.pharmthera.2020.107647.
   PubMed Web of Science ®Google Scholar
• Zhang J, Wang R, Xie H, Yin Q, Jia Z, Li W. 2014. Effect of acute exposure to high altitude on pharmacokinetics of propranolol and metoprolol in rats. Nan Fang Yi Ke Da Xue Xue Bao. 34:1616–1620.
   PubMedGoogle Scholar
• Zhao X, Li S, Ba S, He F, Li N, Ke L, Li X, Lam C, Yan LL, Zhou Y, et al. 2012. Prevalence, awareness, treatment, and control of hypertension among herdsmen living at 4,300 m in Tibet. Am J Hypertens. 25(5):583–589. doi: 10.1038/ajh.2012.9.
   PubMed Web of Science ®Google Scholar
• Zhou SF, Xue CC, Yu XQ, Li C, Wang G. 2007. Clinically important drug interactions potentially involving mechanism-based inhibition of cytochrome P450 3A4 and the role of therapeutic drug monitoring. Ther Drug Monit. 29(6):687–710. doi: 10.1097/FTD.0b013e31815c16f5.
   PubMed Web of Science ®Google Scholar
• Zhou X, Nian Y, Qiao Y, Yang M, Xin Y, Li X. 2018. Hypoxia plays a key role in the pharmacokinetic changes of drugs at high altitude. Curr Drug Metab. 19(11):960–969. doi: 10.2174/1389200219666180529112913.
   PubMed Web of Science ®Google Scholar
• Zhou X, Nian Y, Yang M, Xin Y, Qiao Y, Zhu L, Yang J, Li X. 2017. The protein and mRNA expression of drug transports MDR1, MRP1 and BCRP after exposure to high altitude hypoxia. Chin High Alt Med Biol. 38:183–187.
   Google Scholar
• Zhu J, Duan Y, Duo D, Yang J, Bai X, Liu G, Wang Q, Wang X, Qu N, Zhou Y, et al. 2022. High-altitude hypoxia influences the activities of the drug-metabolizing enzyme CYP3A1 and the pharmacokinetics of four cardiovascular system drugs. Pharmaceuticals. 15(10):1303. doi: 10.3390/ph15101303.
   Web of Science ®Google Scholar